ALK and chronic myelogenous leukemia, BCR-ABL1 positive: We further explored long-read-based fusion transcript detection using transcriptomes from nine cancer cell lines derived from diverse cancer types including breast cancer (SKBR3, HCC1187, HCC1395), prostate cancer (VCaP), CML (K562), ALK+ anaplastic large cell lymphoma (KIJK), T cell lymphoma (MJ), small cell lung cancer (DMS53), and urothelial bladder cancer (RT112).